[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to content
BY 4.0 license Open Access Published by De Gruyter Open Access March 13, 2023

Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”

  • Ying Zhong EMAIL logo , Zhiqun Zhang and Xiaoqing Chen
From the journal Open Medicine
This erratum corrects the original online version which can be found here: https://doi.org/10.1515/med-2022-0584

In the published article Zhong Y, Zhang Z, Chen X. Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway. Open Med. (Wars) 2022 Dec 9;17(1):1949–1964. doi: 10.1515/med-2022-0584. PMID: 36561848; PMCID: PMC9743197, authors requested to replace Figures 1, 3, 5, 7 with more representative ones. The changes do not affect the results and conclusions of the study.

Figure 1 
            Inhibition of miR-21 improves the angiogenic activity of PMVECs. (a) RT-qPCR was used to measure miR-21 expression in PMVECs treated with RA or hyperoxia (4, 16, and 24 h). (b) The knockdown efficiency of miR-21 inhibitor in PMVECs treated with 24 h of hyperoxia was detected by RT-qPCR. (c) Transwell assay was applied for measuring the migration of hyperoxia-induced PMVECs when miR-21 was silenced. (d) Tube formation assay was performed to estimate the angiogenic activity of hyperoxia-induced PMVECs after miR-21 inhibition. Quantified values are mean values ± standard deviation of at least three independent experiments. **p < 0.01.
Figure 1

Inhibition of miR-21 improves the angiogenic activity of PMVECs. (a) RT-qPCR was used to measure miR-21 expression in PMVECs treated with RA or hyperoxia (4, 16, and 24 h). (b) The knockdown efficiency of miR-21 inhibitor in PMVECs treated with 24 h of hyperoxia was detected by RT-qPCR. (c) Transwell assay was applied for measuring the migration of hyperoxia-induced PMVECs when miR-21 was silenced. (d) Tube formation assay was performed to estimate the angiogenic activity of hyperoxia-induced PMVECs after miR-21 inhibition. Quantified values are mean values ± standard deviation of at least three independent experiments. **p < 0.01.

Figure 3 
            Overexpression of miR-21 strengthens the effects of hyperoxia in PMVECs. (a) The overexpression efficiency of miR-21 mimic in PMVECs treated with 24 h of hyperoxia was detected by RT-qPCR. (b) Transwell assay was applied to detect the migration of hyperoxia-induced PMVECs after miR-21 overexpression. (c) Tube formation assay was performed to estimate the angiogenic activity of hyperoxia-induced PMVECs after miR-21 overexpression. (d) Western blot was utilized to test the p-eNOS (ser1177) level in PMVECs of different groups (RA group, hyperoxia-24 h group, hyperoxia-24 h + NC mimic group, hyperoxia-24 h + miR-21 mimic group). (e–g) ELISA was utilized to detect the NO production and the intracellular and extracellular ADMA concentration in PMVECs of different groups. Quantified values are mean values ± standard deviation of at least three independent experiments. **p < 0.01, ***p < 0.001.
Figure 3

Overexpression of miR-21 strengthens the effects of hyperoxia in PMVECs. (a) The overexpression efficiency of miR-21 mimic in PMVECs treated with 24 h of hyperoxia was detected by RT-qPCR. (b) Transwell assay was applied to detect the migration of hyperoxia-induced PMVECs after miR-21 overexpression. (c) Tube formation assay was performed to estimate the angiogenic activity of hyperoxia-induced PMVECs after miR-21 overexpression. (d) Western blot was utilized to test the p-eNOS (ser1177) level in PMVECs of different groups (RA group, hyperoxia-24 h group, hyperoxia-24 h + NC mimic group, hyperoxia-24 h + miR-21 mimic group). (e–g) ELISA was utilized to detect the NO production and the intracellular and extracellular ADMA concentration in PMVECs of different groups. Quantified values are mean values ± standard deviation of at least three independent experiments. **p < 0.01, ***p < 0.001.

Figure 5 
            DDAH1 knockdown reverses the effects of miR-21 depletion on hyperoxia-induced PMVEC behaviors, NO production, and ADMA concentration. (a) Western blot was performed to test the knockdown efficiency of si-DDAH1 in hyperoxia-induced PMVECs. (b) Transwell assay was applied for measuring the migration of hyperoxia-induced PMVECs in different groups (NC inhibitor group, miR-21 inhibitor group, miR-21 inhibitor + si-NC group, miR-21 inhibitor + si-DDAH1 group). (c) Tube formation assay was performed to estimate the angiogenic activity of hyperoxia-induced PMVECs in different groups. (d) Western blot was utilized to test the p-eNOS (ser1177) level in hyperoxia-induced PMVECs of different groups. (e and f) ELISA was utilized to detect the NO production and the extracellular ADMA concentration in hyperoxia-induced PMVECs of different groups. Quantified values are mean values ± standard deviation of at least three independent experiments. * p < 0.05, **p < 0.01.
Figure 5

DDAH1 knockdown reverses the effects of miR-21 depletion on hyperoxia-induced PMVEC behaviors, NO production, and ADMA concentration. (a) Western blot was performed to test the knockdown efficiency of si-DDAH1 in hyperoxia-induced PMVECs. (b) Transwell assay was applied for measuring the migration of hyperoxia-induced PMVECs in different groups (NC inhibitor group, miR-21 inhibitor group, miR-21 inhibitor + si-NC group, miR-21 inhibitor + si-DDAH1 group). (c) Tube formation assay was performed to estimate the angiogenic activity of hyperoxia-induced PMVECs in different groups. (d) Western blot was utilized to test the p-eNOS (ser1177) level in hyperoxia-induced PMVECs of different groups. (e and f) ELISA was utilized to detect the NO production and the extracellular ADMA concentration in hyperoxia-induced PMVECs of different groups. Quantified values are mean values ± standard deviation of at least three independent experiments. * p < 0.05, **p < 0.01.

Figure 7 
            MiR-21 antagomir restores alveolarization and vascular density in neonatal rats with BPD. (a) H&E staining assay was utilized to detect the histopathological alterations of rats in different groups (air group, BPD group, BPD + NC antagomir group, BPD + miR-21 antagomir group). (b and c) The radial alveolar count and the alveolar area/pulmonary septal area value were detected. (d and e) Immunofluorescence staining was applied for measuring the vWF-positive vessels in different groups. N = 12. Quantified values are mean values ± standard deviation of at least three independent experiments. * p < 0.05, **p < 0.01.
Figure 7

MiR-21 antagomir restores alveolarization and vascular density in neonatal rats with BPD. (a) H&E staining assay was utilized to detect the histopathological alterations of rats in different groups (air group, BPD group, BPD + NC antagomir group, BPD + miR-21 antagomir group). (b and c) The radial alveolar count and the alveolar area/pulmonary septal area value were detected. (d and e) Immunofluorescence staining was applied for measuring the vWF-positive vessels in different groups. N = 12. Quantified values are mean values ± standard deviation of at least three independent experiments. * p < 0.05, **p < 0.01.

Received: 2023-03-01
Accepted: 2023-03-01
Published Online: 2023-03-13

© 2023 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 5.2.2025 from https://www.degruyter.com/document/doi/10.1515/med-2023-0679/html
Scroll to top button